Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 AUD | -1.54% |
|
-3.03% | -11.11% |
06-28 | Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3% | MT |
04-23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.11% | 48.45M | |
-20.57% | 8.17B | |
+71.21% | 4.4B | |
+9.44% | 2.77B | |
-2.10% | 2.61B | |
-15.14% | 1.75B | |
-57.71% | 1.69B | |
-16.46% | 1.45B | |
+19.97% | 1.24B | |
-50.19% | 1.01B |
- Stock Market
- Equities
- MAP Stock
- News Microba Life Sciences Limited
- Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%